Non-Clinical Topics   /   News

Pesticides Plus Gene Variant Increase Parkinson’s Risk

By US Medicine

LOS ANGELES – Exposure to pesticides may increase the risk of Parkinson’s disease, and certain gene variants may make some people even more susceptible to the disease, according to a new study.

The research, published recently in the journal Neurology, indicates that specific pesticides inhibiting aldehyde dehydrogenase (ALDH) are linked to an increased risk of Parkinson’s disease. The enzyme helps detoxify substances in cells and has a role in metabolism of alcohol, the authors note.1

In addition, people with a variant of the ALDH2 gene were two to five times more likely to develop Parkinson’s disease with exposure to these pesticides than people who did not have that gene variant, the report pointed out.

“These results show that ALDH inhibition appears to be an important mechanism through which pesticides may contribute to the development of Parkinson’s disease,” said study author Jeff M. Bronstein, MD, PhD, of the Los Angeles VAMC and the David Geffen School of Medicine at UCLA. “Understanding this mechanism may reveal several potential targets for preventing the disease from occurring or reducing its progression.”

For the study, researchers focused on 360 Parkinson’s disease patients in three rural California counties, comparing them to 816 people in the area who did not have the disease. Participants’ exposure to pesticides at work and at home was measured using a geographic computer model based on information from the California Department of Pesticide Regulation.

Using a test to identify which pesticides inhibited ALDH, the researchers determined that the 11 pesticides that inhibited ALDH, all used in farming, fell into four structural classes — dithiocarbamates, imidazoles, dicarboxymides and organochlorides.

Study results found that exposure to an ALDH-inhibiting pesticide at both the workplace and at home was associated with increased risks of developing Parkinson’s disease, ranging from 65% for the pesticide benomyl to six times the risk for the pesticide dieldrin. In fact, those exposed to three or more of the pesticides at both work and home were 3.5 times more likely to develop Parkinson’s disease as those who were not exposed.

The relationship between the gene variant and Parkinson’s only appeared when people had been exposed to the pesticides, however.

“In other words, having this gene variant alone does not make you more likely to develop Parkinson’s,” he said. “Parkinson’s is a disease that in many cases may require both genetics and environmental factors to arise.”

1 Fitzmaurice AG, Rhodes SL, Cockburn M, Ritz B, Bronstein JM. Aldehyde dehydrogenase variation enhances effect of pesticides associated with Parkinson’s disease. Neurology. 2014 Feb 4;82(5):419-26. doi: 10.1212/WNL.0000000000000083. PubMed PMID: 24491970; PubMed Central PMCID: PMC3917685.

 


Related Articles

Shulkin Ousted, White House Physician Nominated for VA Secretary

WASHINGTON — After several weeks of speculation regarding his future in the Trump Administration, VA Secretary David Shulkin, MD’s tenure came to an abrupt end on March 28.

First-Ever Study Focuses on How Well VHA Cares for TIA Patients

INDIANAPOLIS — While many healthcare systems measure the quality of their stroke care, looking at performance early in the vascular disease process can help avoid acute events altogether.


U.S. Medicine Recommends


More From department of defense dod

Department of Defense (DoD)

GAO: ‘Gaps’ in MHS Physician Specialties Could Affect Wartime Readiness

Vascular Events Lead to Stroke About a Fourth of the Time. INDIANAPOLIS — While many healthcare systems measure the quality of their stroke care, looking at performance early in the vascular disease process can help... View Article

Department of Veterans Affairs (VA)

VA Vows to Meet Deadline for Revamp of Veteran Claims Appeal Process

Vascular Events Lead to Stroke About a Fourth of the Time. INDIANAPOLIS — While many healthcare systems measure the quality of their stroke care, looking at performance early in the vascular disease process can help... View Article

Department of Defense (DoD)

DoD, VA Still Struggle with Diagnosing, Treating Mild Traumatic Brain Injuries

Diagnosing and treating mild traumatic brain injury continues to pose challenges for clinicians, TBI experts told lawmakers.

Department of Defense (DoD)

VA Promises to Resolve Late Payment Issues with Community Healthcare Providers

Vascular Events Lead to Stroke About a Fourth of the Time. INDIANAPOLIS — While many healthcare systems measure the quality of their stroke care, looking at performance early in the vascular disease process can help... View Article

Department of Defense (DoD)

Change in VA/DoD Guidelines for Low Back Pain Surprising Even for Authors

If VA clinicians are surprised by the significant changes in the updated recommendations recently issued by the VA and DoD for the diagnosis and management of low back pain, they are not alone. The evidence review even shocked many members of the work group that wrote the new clinical practice guidelines.

Facebook Comment

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up